BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 25803720)

  • 1. Microbiological screening is necessary to distinguish carriers of plasmid-mediated AmpC beta-lactamase-producing enterobacteriaceae and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae because of clinical similarity.
    Conen A; Frei R; Adler H; Dangel M; Fux CA; Widmer AF
    PLoS One; 2015; 10(3):e0120688. PubMed ID: 25803720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of plasmid-mediated β-lactamases in fecal colonizing patients in the hospital and community setting in Spain.
    Garrido A; Seral C; Gude MJ; Casado C; González-Domínguez M; Sáenz Y; Castillo FJ
    Microb Drug Resist; 2014 Aug; 20(4):301-4. PubMed ID: 24328895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-spectrum β-lactamase- and pAmpC-producing Enterobacteriaceae among the general population in a livestock-dense area.
    Wielders CCH; van Hoek AHAM; Hengeveld PD; Veenman C; Dierikx CM; Zomer TP; Smit LAM; van der Hoek W; Heederik DJ; de Greeff SC; Maassen CBM; van Duijkeren E
    Clin Microbiol Infect; 2017 Feb; 23(2):120.e1-120.e8. PubMed ID: 27773759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors of community-onset urinary tract infections caused by plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae.
    Lee CH; Lee YT; Kung CH; Ku WW; Kuo SC; Chen TL; Fung CP
    J Microbiol Immunol Infect; 2015 Jun; 48(3):269-75. PubMed ID: 24239065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities and detection performances of cefmetazole and flomoxef for extended-spectrum β-lactamase and plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae.
    Matsumura Y; Yamamoto M; Nagao M; Tanaka M; Takakura S; Ichiyama S
    Diagn Microbiol Infect Dis; 2016 Apr; 84(4):322-7. PubMed ID: 26782634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for faecal colonisation with Escherichia coli producing extended-spectrum and plasmid-mediated AmpC β-lactamases in dogs.
    Belas A; Salazar AS; Gama LT; Couto N; Pomba C
    Vet Rec; 2014 Aug; 175(8):202. PubMed ID: 24943100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
    Bert F; Larroque B; Dondero F; Durand F; Paugam-Burtz C; Belghiti J; Moreau R; Nicolas-Chanoine MH
    Transpl Infect Dis; 2014 Feb; 16(1):84-9. PubMed ID: 24330161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The presence of extended spectrum beta-lactamase, KPC-type carbapenemase and plasmid-mediated AmpC beta-lactamase in E.coli and K.pneumoniae strains isolated from blood cultures].
    Baykal A; Cöplü N; Simşek H; Esen B; Gür D
    Mikrobiyol Bul; 2012 Apr; 46(2):159-69. PubMed ID: 22639305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal carriage of extended-spectrum beta-lactamase and ampc beta-lactamase-producing enterobacteriaceae in a turkish community.
    Hazirolan G; Mumcuoglu I; Altan G; Özmen BB; Aksu N; Karahan ZC
    Niger J Clin Pract; 2018 Jan; 21(1):81-86. PubMed ID: 29411729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of ESBL- and AmpC-Producing Enterobacteriaceae from Diseased Companion Animals in Europe.
    Bogaerts P; Huang TD; Bouchahrouf W; Bauraing C; Berhin C; El Garch F; Glupczynski Y;
    Microb Drug Resist; 2015 Dec; 21(6):643-50. PubMed ID: 26098354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting carriage with extended-spectrum beta-lactamase-producing bacteria at hospital admission: a cross-sectional study.
    Platteel TN; Leverstein-van Hall MA; Cohen Stuart JW; Thijsen SF; Mascini EM; van Hees BC; Scharringa J; Fluit AC; Bonten MJ
    Clin Microbiol Infect; 2015 Feb; 21(2):141-6. PubMed ID: 25658554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of rates of fecal colonization with extended-spectrum beta-lactamase-producing enterobacteria among patients in different wards, outpatients and medical students.
    Ebrahimi F; Mózes J; Monostori J; Gorácz O; Fésűs A; Majoros L; Szarka K; Kardos G
    Microbiol Immunol; 2016 May; 60(5):285-94. PubMed ID: 26959958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.
    Lübbert C; Straube L; Stein C; Makarewicz O; Schubert S; Mössner J; Pletz MW; Rodloff AC
    Int J Med Microbiol; 2015 Jan; 305(1):148-56. PubMed ID: 25547265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of transmission of extended-spectrum beta-lactamase-producing enterobacteriaceae without contact isolation.
    Tschudin-Sutter S; Frei R; Dangel M; Stranden A; Widmer AF
    Clin Infect Dis; 2012 Dec; 55(11):1505-11. PubMed ID: 22955436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-spectrum beta-lactamase-producing Enterobacteriaceae carriage upon hospital admission: prevalence and risk factors.
    Shitrit P; Reisfeld S; Paitan Y; Gottesman BS; Katzir M; Paul M; Chowers M
    J Hosp Infect; 2013 Nov; 85(3):230-2. PubMed ID: 24080081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of extended-spectrum β-lactamase and AmpC β-lactamase-producing Enterobacteriaceae isolated from companion animals in New Zealand.
    Karkaba A; Grinberg A; Benschop J; Pleydell E
    N Z Vet J; 2017 Mar; 65(2):105-112. PubMed ID: 27973988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian University Hospital.
    Schoevaerdts D; Bogaerts P; Grimmelprez A; de Saint-Hubert M; Delaere B; Jamart J; Swine C; Glupczynski Y
    BMC Infect Dis; 2011 Jan; 11():12. PubMed ID: 21226923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and risk factors of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in a medical center in Taiwan: a prospective cohort study.
    Kung CH; Ku WW; Lee CH; Fung CP; Kuo SC; Chen TL; Lee YT
    J Microbiol Immunol Infect; 2015 Apr; 48(2):168-74. PubMed ID: 24064292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of extended-spectrum β-lactamase (ESBL)- and pAmpC beta-lactamase-producing Enterobacteriaceae of water samples in Tunisia.
    Ben Said L; Jouini A; Alonso CA; Klibi N; Dziri R; Boudabous A; Ben Slama K; Torres C
    Sci Total Environ; 2016 Apr; 550():1103-1109. PubMed ID: 26871556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospitalization.
    Friedmann R; Raveh D; Zartzer E; Rudensky B; Broide E; Attias D; Yinnon AM
    Infect Control Hosp Epidemiol; 2009 Jun; 30(6):534-42. PubMed ID: 19419270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.